Combining immunotherapy with high-dose radiation therapy (HDRT) significantly inhibits tumor growth in a syngeneic mouse model of high-risk neuroblastoma

Boboila, S., Okochi, S., Banerjee, D., Barton, S., Street, C., Zenilman, A. L., Wang, Q., Gartrell, R. D., Saenger, Y. M., Welch, D., Wu, C.-C., Kadenhe-Chiweshe, A., Yamashiro, D. J., & Connolly, E. P. (2023). Combining immunotherapy with high-dose radiation therapy (HDRT) significantly inhibits tumor growth in a syngeneic mouse model of high-risk neuroblastoma. Heliyon, 9(6), e17399. https://doi.org/10.1016/j.heliyon.2023.e17399
Authors:
Shuobo Boboila
Shunpei Okochi
Debarshi Banerjee
Sunjay M. Barton
Cherease Street
Ariela Zenilman
Qi Wang
Robyn D. Gartrell
Yvonne M. Saenger
David Welch
Cheng‐Chia Wu
Angela V. Kadenhe‐Chiweshe
Darrell J. Yamashiro
Eileen P. Connolly
Affiliated Authors:
Shuobo Boboila
Shunpei Okochi
Debarshi Banerjee
Sunjay M. Barton
Cherease Street
Ariela Zenilman
Qi Wang
Robyn D. Gartrell
Yvonne M. Saenger
David Welch
Cheng‐Chia Wu
Angela V. Kadenhe‐Chiweshe
Darrell J. Yamashiro
Eileen P. Connolly
Author Keywords:
cancer therapeutics
combination therapy
high dose radiation therapy
immunotherapy
mycn-amplified neuroblastoma
neuroblastoma
novel syngeneic mouse model
Publication Type:
Article
Unique ID:
10.1016/j.heliyon.2023.e17399
PMID:
Journal:
Publication Date:
Data Source:
OpenAlex

Record Created: